Drawing for FLOW CAPS LIQUID TECHNOLOGY

USPTO serial 79117496

FLOW CAPS LIQUID TECHNOLOGY

Reviewed by CopyMark Law Group

Reg. 4362850Status 706Registered
Filing date
Status date
Registration date
Jul 9, 2013
Examiner
ALTREE, NICHOLAS
Law office
GENERIC WEB UPDATE

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with FLOW CAPS LIQUID TECHNOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

N. Alexander Nolte

N. Alexander Nolte NOLTE LACKENBACH SIEGEL111 Brook Street, Suite 101Scarsdale, NY 10583UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes, pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; medicines for human purposes, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes, for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; dietetic foods adapted for medical purposes, namely, health food supplements for humans, mineral food supplements, dietary supplements, energizing nutritional supplements used in prophylaxis and in convalescence; high-protein nutritional concentrates and supplements, not for medical purposes, enriched with vitamins, mineral salts and amino acids; nutritional carbohydrate concentrates, nutritional carbohydrate and high-energy supplements not for medical purposes, enriched with vitamins and mineral salts; food supplements, namely, high protein powders for nutritional purposes; food supplements, namely, carbohydrate powders for nutritional purposesACTIVE—
029[ milk products excluding ice cream, ice milk and frozen yogurt ]SECTION 71 - CANCELLED—
030[ cereal bars; muesli bars, including muesli energy snack bars ]SECTION 71 - CANCELLED—
035[ advertising services, wholesale and retail stores and online wholesale and retail stores all featuring food supplements, dietetic foods, pharmaceutical preparations, and beverages ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 7, 2024INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Nov 13, 2024INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Nov 12, 2024INPCINVALIDATION PROCESSED—
Oct 23, 2024INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 22, 2024NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Feb 22, 202471AGREGISTERED-SEC.71 ACCEPTED—
Feb 12, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 19, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 7, 2023ES71TEAS SECTION 71 RECEIVED—
Jul 9, 2022REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Mar 10, 2022RNWLINTERNATIONAL REGISTRATION RENEWED—
Jul 24, 2020INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Jun 10, 2020INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jun 10, 2020INPCINVALIDATION PROCESSED—
Apr 27, 2020INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Aug 27, 2019NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Aug 27, 2019C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.—
Aug 7, 2019APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 9, 2019ES75TEAS SECTION 71 & 15 RECEIVED—
Apr 25, 2019ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jul 9, 2018REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 27, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 9, 2013FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 9, 2013FIMPFINAL DISPOSITION PROCESSED—
Oct 9, 2013FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 9, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 23, 2013GPNXNOTIFICATION PROCESSED BY IB—
Apr 23, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 23, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 3, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 3, 2013OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Apr 3, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 20, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 19, 2013ALIEASSIGNED TO LIE—
Mar 7, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 7, 2013XAECEXAMINER'S AMENDMENT ENTERED—
Mar 7, 2013GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 7, 2013GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 7, 2013CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 4, 2013GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Mar 4, 2013GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 4, 2013CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 2, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 1, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 1, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 24, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 24, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 19, 2012RFNTREFUSAL PROCESSED BY IB—
Oct 15, 2012RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 15, 2012RFRRREFUSAL PROCESSED BY MPU—
Oct 14, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 13, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 4, 2012MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 30, 2012DOCKASSIGNED TO EXAMINER—
Sep 30, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 27, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance